Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Mar 13, 2014
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Award
Restricted Share Units
2014-03-11+502,996→ 502,996 total→ Common Shares, no par value (502,996 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents the right to receive one share of Registrant common stock.
- [F2]On May 24, 2013, the Registrant delivered 502,996 vested performance share units (the "2010 PSU Grant") to Mr. Pearson in error. In connection with Mr. Pearson returning to the Registrant the value of such shares on the date of delivery (plus interest), Mr. Pearson has been credited with 502,996 vested share units to be delivered to him in accordance with the terms of the original 2010 PSU Grant.
- [F3]The performance based RSUs vested on May 24, 2013 on achievement of the applicable performance criteria. The performance based RSUs are generally not issuable until 2019 pursuant to Mr. Pearson's employment agreement.